Kamil Kiełbasiński

All Stories

1. 
   Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line

   Article • Current Pharmaceutical Biotechnology, October 2020, Bentham Science Publishers

   Kamil Kiełbasiński

2. 
   Salinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer

   Article • Current Pharmaceutical Biotechnology, June 2020, Bentham Science Publishers

   Kamil Kiełbasiński

3. 
   Assessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial Cancer

   Article • Current Pharmaceutical Biotechnology, January 2020, Bentham Science Publishers

   Kamil Kiełbasiński

4. 
   Variances in the Level of COX-2 and iNOS in Different Grades of Endometrial Cancer

   Article • Current Pharmaceutical Biotechnology, January 2020, Bentham Science Publishers

   Kamil Kiełbasiński, Przemyslaw Kieszkowski

5. 
   Assessment of expression of Homeobox A5 in endometrial cancer on the mRNA and protein level

   Article • Current Pharmaceutical Biotechnology, December 2019, Bentham Science Publishers

   Kamil Kiełbasiński

6. 
   Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study

   Article • Current Pharmaceutical Biotechnology, September 2019, Bentham Science Publishers

   Przemyslaw Kieszkowski, Kamil Kiełbasiński

7. 
   Expression profile of VEGF-C, VEGF-D, VEGFR-3 in different grades of endometrial cancer

   Article • Current Pharmaceutical Biotechnology, July 2019, Bentham Science Publishers

   Kamil Kiełbasiński, Dr Tomasz Halski